A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19

We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab. Although COVID-associated pulmonary aspergillosis has been widely documented, mucormycosis has been rarely reported. In this patient, receipt o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanwar, Anubhav, Jordan, Alex, Olewiler, Scott, Wehberg, Kurt, Cortes, Michael, Jackson, Brendan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997212/
https://www.ncbi.nlm.nih.gov/pubmed/33670842
http://dx.doi.org/10.3390/jof7030174
Descripción
Sumario:We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab. Although COVID-associated pulmonary aspergillosis has been widely documented, mucormycosis has been rarely reported. In this patient, receipt of two commonly used immunosuppressants likely contributed to mucormycosis risk, suggesting the need for vigilance in hospitalized patients with COVID-19.

Ejemplares similares